WebAcquired hemophilia A (AHA) is a severe bleeding disorder with high mortality rates resulting from the development of autoantibodies to factor VIII (FVIII). Patients typically present with hemorrhages in the skin, subcutaneous tissues, and muscles, which are frequently severe. WebMay 6, 2006 · Dr. David M Aboulafia has a medical practice at 380 Winslow Way East, Bainbridge Island, WA. Dr. David M Aboulafia specializes in hematology oncology and has over 40 years of experience in the field of medicine. He is affiliated with numerous hospitals, including Virginia Mason Medical Center (WA) and more.
Initial experience with topical fluorouracil (5-FU) for treatment of ...
WebDr. David Aboulafia graduated from University of Michigan Medical School in 1983. Dr. Aboulafia has six offices in Washington where he specializes in Hematology / Oncology and Internal Medicine. Dr. Aboulafia works with four hundred and twenty-four doctors including Dr. Amy Brockmeyer and Dr. Geoffrey Jiranek . Specialties Hematology / Oncology our daily bread app problems
Cyclophosphamide Treatment for Acquired Factor VIII Inhibitor in …
WebDr. David Aboulafia, MD is a Hematology & Oncology Specialist in Seattle, WA. Dr. Aboulafia completed a residency at U Calif Hosps-Clins. They currently practice at … WebFeb 1, 2014 · *Paul G. Rubinstein and David M. Aboulafia contributed equally to the writing of this article. ORCIDs linked to this article. Zloza A, 0000-0001-8844-6493, Rush University Medical Center; Rubinstein PG, 0000-0002-0724-461X, John H. Stroger Hospital of Cook County (Cook County Hospital) AIDS ... WebMay 26, 2015 · Cyclophosphamide Treatment for Acquired Factor VIII Inhibitor in a Patient with AIDS-Associated Progressive Multifocal Leukoencephalopathy - Uma Malhotra, David M. Aboulafia, 2016 Browse by discipline Information for Journal of the International Association of Providers of AIDS Care (JIAPAC) Journal indexing and metrics JOURNAL … roehampton university hr